DekaBank Deutsche Girozentrale’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-76,282
| Closed | -$465K | – | 1072 |
|
|
2019
Q2 | $465K | Sell |
76,282
-32,159
| -30% | -$193K | ﹤0.01% | 930 |
|
|
2019
Q1 | $1.27M | Buy |
108,441
+26,022
| +32% | +$158K | 0.01% | 711 |
|
|
2018
Q4 | $528K | Sell |
82,419
-26,022
| -24% | -$211K | ﹤0.01% | 819 |
|
|
2018
Q3 | $1.27M | Sell |
108,441
-1,000
| -0.9% | -$11.5K | 0.01% | 723 |
|
|
2018
Q2 | $1.36M | Buy |
109,441
+2,000
| +2% | +$20.5K | 0.01% | 679 |
|
|
2018
Q1 | $899K | Sell |
107,441
-36,000
| -25% | -$333K | 0.01% | 745 |
|
|
2017
Q4 | $2.08M | Hold |
143,441
| – | – | 0.02% | 536 |
|
|
2017
Q3 | $2.08M | Hold |
143,441
| – | – | 0.02% | 544 |
|
|
2017
Q2 | $2.37M | Buy |
+143,441
| New | +$2.22M | 0.02% | 514 |
|
|
2016
Q3 | – | Sell |
-51,741
| Closed | -$735K | – | 998 |
|
|
2016
Q2 | $735K | Buy |
51,741
+7,100
| +16% | +$96.3K | 0.01% | 596 |
|
|
2016
Q1 | $549K | Sell |
44,641
-8,100
| -15% | -$84.9K | 0.01% | 638 |
|
|
2015
Q4 | $705K | Buy |
52,741
+600
| +1% | +$7.38K | 0.01% | 625 |
|
|
2015
Q3 | $560K | Buy |
52,141
+1,300
| +3% | +$14.2K | 0.01% | 672 |
|
|
2015
Q2 | $409K | Buy |
50,841
+2,355
| +5% | +$17.3K | ﹤0.01% | 739 |
|
|
2015
Q1 | $320K | Buy |
48,486
+9,072
| +23% | +$61.9K | ﹤0.01% | 813 |
|
|
2014
Q4 | $239K | Sell |
39,414
-3,643
| -8% | -$29.4K | ﹤0.01% | 827 |
|
|
2014
Q3 | $425K | Buy |
43,057
+857
| +2% | +$9.15K | 0.01% | 693 |
|
|
2014
Q2 | $476K | Sell |
42,200
-2,429
| -5% | -$26.1K | 0.01% | 604 |
|
|
2014
Q1 | $540K | Buy |
44,629
+2,858
| +7% | +$36.5K | 0.01% | 564 |
|
|
2013
Q4 | $529K | Buy |
41,771
+857
| +2% | +$13.6K | 0.01% | 535 |
|
|
2013
Q3 | $682K | Buy |
+40,914
| New | +$686K | 0.01% | 503 |
|
Other funds holding LXRX
AG
UL
BC
NMC
